Lexicon Pharmaceuticals, Inc. currently offers three late-stage assets Zynquista, Inpefa & Pilavapadin. Learn more about LXRX ...

If the jingle singer in the Jardiance commercials looks familiar, you may have seen her on reality TV. Or you may have heard some of her spicy online takes. Either way, she's becoming impossible to ...

In 1969, a now-iconic commercial first popped the question, “How many licks does it take to get to the Tootsie Roll center of a Tootsie Pop?” This deceptively simple line in a 30-second script managed ...

Maryland’s Prescription Drug Affordability Board says it has identified two diabetes drugs that could be made more affordable for residents based on a cost study by the state agency. During a meeting ...

Not that anyone asked, but uranium enrichment is certainly a newsworthy topic where a little science might be helpful. Here's how it's done. Plus, at no extra charge and for no good reason, a ...

Some health-obsessed Americans believe the next antiaging therapeutic already exists—in the medicine cabinets of millions of diabetes patients. The widely used class of drugs, called SGLT2 inhibitors ...

INGELHEIM, Germany, April 2 (Reuters) - Germany's largest pharmaceutical company Boehringer Ingelheim on Wednesday reported a currency-adjusted 6.1% gain in 2024 revenues, buoyed by diabetes drug ...

“Unfortunately, a quarter of people who survive a stroke will have another stroke,” said lead study author Dr. M. Ali Sheffeh. “They are also at risk for other cardiovascular events such as a heart ...

With JetBrains making its Rider and WebStorm IDEs freely available for non-commercial use, Visual Studio 2022 Community Edition has a new competitor, not to mention Visual Studio Code. So what's a ...

After many months of closely watched negotiations, the Centers for Medicare & Medicaid Services (CMS) announced the list of negotiated prices for 10 drugs. This marks the first set of negotiations ...

August 16, 2024 - WASHINGTON - U.S. Senator Amy Klobuchar (D-MN) released the following statement on Thursday’s announcement of the results of the first round of Medicare price negotiations. These ...